drug

ACP-204

1 story · latest Sep 29, 2026

Status: Investigational
Trials: 4 registered trials in coverage

Relationships

Developed by ACADIA Pharmaceuticals Inc.

Timeline

ACADIA's ACP-204 open-label extension study in Lewy body dementia psychosis remains recruiting

Sep 29Trial updateACADIA Pharmaceuticals Inc.ACP-204

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.